All Blogs / Health / Diseases & Conditions / Multiple Sclerosis / New

Looking for Healthcare Answers on the Internet Can Drive You Nuts

I know, I know. I write about health issues on the internet, so I shouldn’t be discouraging people from looking for answers here. But, searching the internet to match symptoms with a diagnosis can be a real anxiety booster. Emily Sohn...Show More Summary

Medical Cannabis Found to Safely Reduce Chronic Pain in Older Patients in Study

Medical cannabis was found to safely and significantly reduce chronic pain in older patients with multiple sclerosis (MS) and a wide range of other conditions, researchers in Israel report. Led by scientists at Ben-Gurion UniversityShow More Summary

The Power of Resilience

After taking a tumble this week, I am reminded of the power of resilience. defines resilience as: “1. the power or ability to return to the original form, position, etc., after being bent, compressed, or stretched; elasticity. Show More Summary

Low-dose Naltrexone Changes Levels of Inflammatory Proteins in MS, Study Shows

Inhibition of the neuroactive opioid growth factor (OGF) alters the blood levels of important pro- and anti-inflammatory proteins in mice with multiple sclerosis (MS)-like disease. The recognition of this regulatory response may represent a new way to monitor disease progression and treatment response in MS. Show More Summary

MS News that Caught My Eye Last Week: Stem Cell Trial, Medical Marijuana, Myelin Repair, Tysabri Study

Stem Cell Treatment Benefits Three-fourths of MS Patients in Phase 1 Trial This is encouraging news for MS patients hoping to see some action in the stem cell area. A Phase 1 mesenchymal stem cell trial is reporting positive results, and a Phase 2 trial is underway in New York. Show More Summary

New Ocrevus Data, Post-FDA Approval, Supports Range of Benefits, Genentech’s Hideki Garren Says

Ocrevus (ocrelizumab), Genentech’s humanized anti-CD20 monoclonal antibody, continues to show clear evidence that it helps to slow disease progression and enable better function — including in the hands and limbs — of relapsing multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS), latest data reveals. Show More Summary

Accelerated Cure Project, Regeneron Unit to Sequence Coding Portion of MS Patients’ Genes

The Accelerated Cure Project for Multiple Sclerosis and a Regeneron unit are teaming up to sequence the coding portion of genes in DNA samples of multiple sclerosis and other patients in the project’s repository. The cure project is a non-profit organization whose goal is to accelerate research to improve MS diagnosis and treatment. Show More Summary

Having a Swell Time

The thing about becoming increasingly immobile is that your consumption of TV, radio, podcasts, books and, indeed, anything written goes up immeasurably. Luckily, one of the creative explosions in the recent years I’ve had MS is Scandi drama. Show More Summary

Peeking Behind the Curtain at Medical Insurance Decisions

Several years ago, I tried to get my insurance company to approve a functional electronic stimulator (FES). It’s a durable medical device that significantly improved my left foot drop. My request was well-supported by documentation from my neurologist and the physical therapist who was evaluating me for the FES. Show More Summary

Inhibiting Enzyme Can Reverse Myelin Damage, Improve Limb Function, Mouse Study Shows

Inhibiting an enzyme responsible for turning genes on and off can reverse damage to the myelin sheath that protects nerve cells, improving limb function, a multiple sclerosis-related study in mice shows. The research, which involved mice with sciatic nerve damage rather than MS, was published in the journal Nature Medicine. Show More Summary

Health Canada Approves Ocrevus to Treat Early Stage PPMS Patients with Active Disease

Primary progressive multiple sclerosis (PPMS) patients in Canada in the earlier stages of this disease can now be treated with Ocrevus (ocrelizumab), following Health Canada‘s decision to approve its use with restrictions. Roche/Genentech’s Ocrevus can be prescribed to adults with early-stage PPMS and characteristic signs of inflammatory activity. Show More Summary

MS and Friends: Not All Are Created Equal

I write in an effort to offer enlightenment. Yet, so often I find I am the one to receive an education. Such was the case with my column on relationships and MS — or more pointedly, the feedback I received. While MS has inflicted anShow More Summary

Optic Neuritis: Commonly Asked Questions

According to the Multiple Sclerosis Society in the UK, optic neuritis is associated with MS. Although the two conditions can be connected, they’re not consequential: not everyone who develops optic neuritis will go on to develop multiple sclerosis. Show More Summary

Clinicians Who Prescribe Cannabis Should ‘Start Low and Go Slow,’ Study Advises

Use of medicinal cannabis may pose risks as it may trigger psychiatric problems, but also because it lacks standardized chemical composition, according to a study published in the Journal of the American Osteopathic Association. With...Show More Summary

FDA Approves Dose of MS Therapy Glatopa That Is Twice as Large as Current One

The U.S. Food and Drug Administration has approved a new dose of Sandoz’s multiple sclerosis therapy Glatopa (glatiramer acetate injection) that is twice as large as the currently authorized one. Regulators’ approval of the 40 mg/mL applies to people with relapsing forms of MS. Show More Summary

The MS Balancing Act: Steady As We Go

Gait and balance issues and MS go together like peanut butter and chocolate. At least they do to me. In one way or another, they’ve been in the foreground of my life since I was diagnosed in 2013. I’ve written about my ups and downs in...Show More Summary

In Sickness and In Health [Sponsored Post]

The post In Sickness and In Health [Sponsored Post] appeared first on Multiple Sclerosis News Today.

Italian Study Examines Tysabri and Risk for Miscarriage and Birth Defects

Pregnant women with multiple sclerosis (MS) exposed to Tysabri (natalizumab) in the first trimester had higher rates of miscarriage and major birth defects in their babies, than women left untreated or treated with interferon beta, a study shows. Show More Summary

7 Videos About Bladder Issues and MS That Might Interest You

According to the National MS Society, approximately 80 percent of MS patients experience some sort of bladder dysfunction. It’s caused by MS lesions which block or delay the signals in the central nervous system that control the bladder and urinary sphincters. Show More Summary

Stem Cell Treatment Benefits Three-fourths of MS Patients in Phase 1 Trial

A stem cell treatment improved the neurological symptoms of three-fourths of the multiple sclerosis patients in a Phase 1 clinical trial, New York researchers reported. The results prompted the team at the Tisch MS Research Center of New York to start a Phase 2 trial to further assess the therapy’s safety and effectiveness. Show More Summary

Copyright © 2015 Regator, LLC